Genetic Study of Pediatric Cardiomyopathy in Children and Their Families

What this Trial Is About

This research aims to understand the genetic causes of cardiomyopathy, a group of heart muscle disorders that affect ventricular function in children. The study focuses on pediatric cardiomyopathy, which is more difficult to diagnose genetically compared to adults, and aims to improve diagnosis and future treatment options. The study is observational and seeks to gather molecular genetic information to help with genetic counseling and understanding normal and abnormal heart function. Participants include children with cardiomyopathy and their family members, whether affected or unaffected. The study does not involve specific treatments but collects genetic data to identify mutations linked to the condition. There is no intervention instead, the study observes and analyzes genetic information over time to support better diagnosis and management. Participants will provide genetic samples and family history details. Researchers will analyze this information to clarify the molecular genetics of cardiomyopathy over a period of 7 years. This data will help elucidate the biology of heart function and inform future counseling and treatment development. The study involves ongoing observation without active treatment, lasting up to the studys completion date in 2030.

Pediatric Cardiomyopathy Mutation Analysis